Morgan Stanley Maintains Equal-Weight on CME Gr, Raises Price Target to $210
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Mike Cyprys has maintained an Equal-Weight rating on CME Group (NASDAQ:CME) and raised the price target from $208 to $210.
July 13, 2023 | 1:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Morgan Stanley has maintained an Equal-Weight rating on CME Group and raised the price target from $208 to $210.
The news is directly related to CME Group. The raised price target by Morgan Stanley indicates a positive outlook for the company, which could lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100